ARCHIVES

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004

ONS Calls For Changes To Resolve Nurse Shortage

June 8, 2001

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997

Medicare: Clinton Budget Revives Proposal To End Physician Drug Markup

February 6, 1998

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999